CN1756533B - 非聚乙二醇化的长期循环的脂质体 - Google Patents
非聚乙二醇化的长期循环的脂质体 Download PDFInfo
- Publication number
- CN1756533B CN1756533B CN2003801100257A CN200380110025A CN1756533B CN 1756533 B CN1756533 B CN 1756533B CN 2003801100257 A CN2003801100257 A CN 2003801100257A CN 200380110025 A CN200380110025 A CN 200380110025A CN 1756533 B CN1756533 B CN 1756533B
- Authority
- CN
- China
- Prior art keywords
- liposome
- compositions
- pegylation
- doxorubicin
- sucrose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
- A61K9/1278—Post-loading, e.g. by ion or pH gradient
Abstract
Description
参数 | 实施例II的组合物 | CAELYX(聚乙二醇化的脂质体阿霉素) | ADRIAMYCIN(常规的非脂质体阿霉素) |
LD<sub>50</sub>(mg/kg) | 16.13 | 13.5 | 10.29 |
MTD(mg/kg) | 8 | 8 | 5 |
参数 | 实施例II的组合物 | CAELYX(聚乙二醇化的脂质体阿霉素) | ADRIAMYCIN(常规的非脂质体阿霉素) |
C<sub>max</sub>(μg/ml) | 267.54 | 285.74 | 26.8 |
T<sub>max</sub>(小时) | 0.085 | 0.085 | 0.085 |
Kel | 0.0997 | 0.07109 | 4.851811 |
T<sub>1/2</sub>(小时) | 6.948 | 9.748 | 0.143 |
AUC(μg-h/ml) | 1694.024 | 2083.215 | 1.244 |
Vd(ml) | 1.480 | 1.688 | 41.42 |
Vd(ml/kg) | 59.20 | 67.52 | 1656.79 |
Cl(ml/h) | 0.15 | 0.12 | 200.96 |
制剂 | 脱毛等级 |
葡萄糖 | - |
空白脂质体 | - |
实施例II的组合物(1mg/kg) | + |
实施例II的组合物(2mg/kg) | + |
实施例II的组合物(3mg/kg) | ++ |
CAELYX(1mg/kg) | 竖毛# |
CAELYX(2mg/kg) | + |
CAELYX(3mg/kg) | ++ |
制剂 | 脱毛等级 |
ADRIAMYCIN(1mg/kg) | + |
ADRIAMYCIN(2mg/kg) | ++ |
ADRIAMYCIN(3mg/kg) | ++++ |
组编号 | 雄性/雌性数目 | 物品 | 总剂量(mg/kg) | 剂量/注射(mg/kg) | 总剂数 |
1 | 0/5 | 盐水 | NA | NA | 3 |
2 | 0/5 | CAELYX | 12 | 4 | 3 |
3 | 0/5 | CAELYX | 6 | 2 | 3 |
4 | 0/5 | 实施例II的组合物 | 12 | 4 | 3 |
5 | 0/5 | 实施例II的组合物 | 6 | 2 | 3 |
组编号 | 雄性/雌性数目 | 物品 | 总剂量(mg/kg) | 剂量/注射(mg/kg) | 总剂数 |
1 | 0/5 | 盐水 | - | - | - |
2 | 0/5 | CAELYX | 12 | 4 | 3 |
3 | 0/5 | CAELYX | 6 | 2 | 3 |
4 | 0/5 | 实施例II的组合物 | 12 | 4 | 3 |
5 | 0/5 | 实施例II的组合物 | 6 | 2 | 3 |
组 | 剂量 | 死亡率 |
对照 | 0 | 0/5 |
实施例II的组合物 | 6mg/kg | 0/5 |
实施例II的组合物 | 12mg/kg | 0/5 |
CAELYX | 6mg/kg | 2/5 |
CAELYX | 12mg/kg | 1/5 |
总盐酸阿霉素含量(DOWEX处理之前) | 4.02mg/ml |
捕获的盐酸阿霉素含量(DOWEX处理之后) | 4mg/ml |
总盐酸阿霉素含量(DOWEX处理之前) | 4.11mg/ml |
捕获的盐酸阿霉素含量(DOWEX处理之后) | 4.10mg/ml |
Claims (49)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1101MU2002 | 2002-12-31 | ||
IN1101/MUM/02 | 2002-12-31 | ||
PCT/IN2003/000424 WO2004058140A2 (en) | 2002-12-31 | 2003-12-31 | Non-pegylated long-circulating liposomes |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1756533A CN1756533A (zh) | 2006-04-05 |
CN1756533B true CN1756533B (zh) | 2010-06-16 |
Family
ID=32500467
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2003801100257A Expired - Fee Related CN1756533B (zh) | 2002-12-31 | 2003-12-31 | 非聚乙二醇化的长期循环的脂质体 |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP1435231B8 (zh) |
JP (1) | JP5355842B2 (zh) |
KR (2) | KR101133084B1 (zh) |
CN (1) | CN1756533B (zh) |
AT (1) | ATE453381T1 (zh) |
AU (1) | AU2003303368B2 (zh) |
BR (1) | BR0317882A (zh) |
CA (1) | CA2511464C (zh) |
DE (1) | DE60330745D1 (zh) |
DK (1) | DK1435231T3 (zh) |
EA (1) | EA008930B1 (zh) |
ES (1) | ES2337563T3 (zh) |
HK (1) | HK1089946A1 (zh) |
IL (1) | IL169364A (zh) |
MX (1) | MXPA05007102A (zh) |
NZ (1) | NZ540778A (zh) |
PT (1) | PT1435231E (zh) |
WO (1) | WO2004058140A2 (zh) |
ZA (1) | ZA200504850B (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2687291A1 (en) | 2007-05-16 | 2008-11-20 | Ktb Tumorforschungsgesellschaft Mbh | Low-viscous anthracycline formulation |
PE20120923A1 (es) * | 2009-03-30 | 2012-08-27 | Eisai Randd Man Co Ltd | Composiciones farmaceuticas comprendiendo liposomas que contiene eribulina o una sal del mismo |
EP2415464B1 (en) | 2009-03-30 | 2017-05-10 | Eisai R&D Management Co., Ltd. | Method for producing liposome composition |
JP2014506922A (ja) * | 2011-03-01 | 2014-03-20 | ティーオー − ビービービー ホールディング ベスローテン フェンノートシャップ | 難水溶性物質の高度なアクティブリポソームローディング |
TW201815418A (zh) * | 2016-09-27 | 2018-05-01 | Vertex Pharma | 使用dna破壞劑及dna-pk抑制劑之組合治療癌症的方法 |
US11083705B2 (en) | 2019-07-26 | 2021-08-10 | Eisai R&D Management Co., Ltd. | Pharmaceutical composition for treating tumor |
CN116570775A (zh) * | 2023-05-16 | 2023-08-11 | 万瑞飞鸿(北京)医疗器材有限公司 | 一种药物涂层、血管支架及其制备方法和应用 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4235871A (en) * | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
EP0153955A1 (en) * | 1983-09-06 | 1985-09-11 | Health Research, Inc. | Liposome delivery method for decreasing the toxicity of an antitumor drug |
CA1270198A (en) * | 1984-08-08 | 1990-06-12 | Marcel B. Bally | Encapsulation of antineoplastic agents in liposomes |
US4880635B1 (en) * | 1984-08-08 | 1996-07-02 | Liposome Company | Dehydrated liposomes |
US4920016A (en) | 1986-12-24 | 1990-04-24 | Linear Technology, Inc. | Liposomes with enhanced circulation time |
CA1338702C (en) * | 1987-03-05 | 1996-11-12 | Lawrence D. Mayer | High drug:lipid formulations of liposomal- antineoplastic agents |
JPH0720857B2 (ja) | 1988-08-11 | 1995-03-08 | テルモ株式会社 | リポソームおよびその製法 |
IL91664A (en) * | 1988-09-28 | 1993-05-13 | Yissum Res Dev Co | Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release |
US6132763A (en) | 1988-10-20 | 2000-10-17 | Polymasc Pharmaceuticals Plc | Liposomes |
US5013556A (en) | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
ES2208946T3 (es) * | 1996-08-23 | 2004-06-16 | Sequus Pharmaceuticals, Inc. | Liposomas que contienen un compuesto de cisplatino. |
NZ511112A (en) * | 1998-09-16 | 2003-11-28 | Alza Corp | Lipsome-entrapped topoisomerase inhibitors |
KR20000061075A (ko) * | 1999-03-23 | 2000-10-16 | 린 중친 | 리포솜의 응집을 방지하기 위한 방법 및 조성물 |
GB0111279D0 (en) * | 2001-05-10 | 2001-06-27 | Nycomed Imaging As | Radiolabelled liposomes |
-
2003
- 2003-12-31 CA CA2511464A patent/CA2511464C/en not_active Expired - Fee Related
- 2003-12-31 JP JP2004562836A patent/JP5355842B2/ja not_active Expired - Fee Related
- 2003-12-31 KR KR1020057012107A patent/KR101133084B1/ko not_active IP Right Cessation
- 2003-12-31 KR KR1020117014172A patent/KR101171045B1/ko not_active IP Right Cessation
- 2003-12-31 EA EA200500850A patent/EA008930B1/ru not_active IP Right Cessation
- 2003-12-31 DE DE60330745T patent/DE60330745D1/de not_active Expired - Lifetime
- 2003-12-31 NZ NZ540778A patent/NZ540778A/en not_active IP Right Cessation
- 2003-12-31 PT PT03258252T patent/PT1435231E/pt unknown
- 2003-12-31 MX MXPA05007102A patent/MXPA05007102A/es active IP Right Grant
- 2003-12-31 ES ES03258252T patent/ES2337563T3/es not_active Expired - Lifetime
- 2003-12-31 AT AT03258252T patent/ATE453381T1/de active
- 2003-12-31 AU AU2003303368A patent/AU2003303368B2/en not_active Ceased
- 2003-12-31 CN CN2003801100257A patent/CN1756533B/zh not_active Expired - Fee Related
- 2003-12-31 BR BR0317882-0A patent/BR0317882A/pt not_active IP Right Cessation
- 2003-12-31 WO PCT/IN2003/000424 patent/WO2004058140A2/en active Application Filing
- 2003-12-31 DK DK03258252.0T patent/DK1435231T3/da active
- 2003-12-31 EP EP03258252A patent/EP1435231B8/en not_active Expired - Lifetime
-
2005
- 2005-06-14 ZA ZA200504850A patent/ZA200504850B/en unknown
- 2005-06-23 IL IL169364A patent/IL169364A/en not_active IP Right Cessation
-
2006
- 2006-09-20 HK HK06110458.8A patent/HK1089946A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ZA200504850B (en) | 2006-08-30 |
KR101171045B1 (ko) | 2012-08-03 |
CA2511464C (en) | 2011-08-23 |
EP1435231B1 (en) | 2009-12-30 |
PT1435231E (pt) | 2010-04-08 |
MXPA05007102A (es) | 2005-08-26 |
WO2004058140B1 (en) | 2004-12-16 |
AU2003303368B2 (en) | 2010-06-17 |
ATE453381T1 (de) | 2010-01-15 |
KR20110075051A (ko) | 2011-07-05 |
EA200500850A1 (ru) | 2006-02-24 |
KR101133084B1 (ko) | 2012-04-04 |
JP2006513189A (ja) | 2006-04-20 |
KR20050088233A (ko) | 2005-09-02 |
JP5355842B2 (ja) | 2013-11-27 |
EP1435231B8 (en) | 2010-03-03 |
AU2003303368A1 (en) | 2004-07-22 |
EA008930B1 (ru) | 2007-08-31 |
IL169364A0 (en) | 2007-07-04 |
BR0317882A (pt) | 2005-12-13 |
NZ540778A (en) | 2008-04-30 |
IL169364A (en) | 2012-05-31 |
DK1435231T3 (da) | 2010-04-26 |
CN1756533A (zh) | 2006-04-05 |
HK1089946A1 (en) | 2006-12-15 |
CA2511464A1 (en) | 2004-07-15 |
DE60330745D1 (de) | 2010-02-11 |
ES2337563T3 (es) | 2010-04-27 |
WO2004058140A3 (en) | 2004-10-28 |
EP1435231A1 (en) | 2004-07-07 |
WO2004058140A2 (en) | 2004-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107811971B (zh) | 用于药物输送的脂质体 | |
US9005655B2 (en) | Non-pegylated long-circulating liposomes | |
Vaage et al. | Therapy of mouse mammary carcinomas with vincristine and doxorubicin encapsulated in sterically stabilized liposomes | |
CN106137967A (zh) | 靶向脑胶质瘤的双重修饰脂质体给药系统的制备和应用 | |
Gulati et al. | Development of liposomal amphotericin B formulation | |
Sheikh et al. | Nanosomal Amphotericin B is an efficacious alternative to Ambisome® for fungal therapy | |
CN105287383A (zh) | 新型米托蒽醌脂质体联合化疗药物在抗肿瘤治疗中的应用 | |
Segarra et al. | Pharmacokinetics and tissue distribution after intravenous administration of a single dose of amphotericin B cochleates, a new lipid‐based delivery system | |
CN1756533B (zh) | 非聚乙二醇化的长期循环的脂质体 | |
CN113440610B (zh) | 共载cd73抗体和阿霉素的脂质体及其制备方法和应用 | |
CN103622909A (zh) | 一种含心磷脂的脂质体新制剂及其在抗肿瘤药物中的应用 | |
CN106821987A (zh) | 一种载含酚羟基难溶性药物的脂质体及制备方法和应用 | |
CN112972421A (zh) | 基于多正电荷蛋白的纳米药物系统、其制备方法及应用 | |
CN102085189B (zh) | 一种多西他赛长循环脂质体的制备方法 | |
CN100479820C (zh) | 伊曲康唑脂质体及其制备方法 | |
CN103933024B (zh) | 用于抗肿瘤的脂质体组合物 | |
CN108926719B (zh) | 用c(RGD-ACP-K)修饰的长循环脂质体 | |
CN1711074B (zh) | 脂质体 | |
CN105616354A (zh) | 一种新藤黄酸脂质体注射剂及其制备方法 | |
CN113288871B (zh) | 用于调控表观遗传与免疫检查点的药物组合物脂质体制剂 | |
WO1993023015A1 (en) | Liposomal aminoglycoside compositions and process for their preparation | |
RU2714137C1 (ru) | Фосфолипидная композиция доксорубицина для лечения больных раком молочной железы | |
CN102138898A (zh) | 抗肿瘤药物纳米脂质体 | |
CN103622906B (zh) | 一种高载药量两性霉素b聚合物复合胶束及其制备方法 | |
GS et al. | Enhanced Tumor Targeting and Antitumor Activity of Gemcitabine Encapsulated Stealth Liposomes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: BSV RESEACH AND DEVELOPMENT PERSONAL CO., LTD. Free format text: FORMER OWNER: BHARAT SERUMS + VACCINES LTD. Effective date: 20061027 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20061027 Address after: Ahmedabad Applicant after: BSV Research and Development Pte. Ltd. Address before: India Fontana Applicant before: Bharat Serums & Vaccines Ltd. |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1089946 Country of ref document: HK |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1089946 Country of ref document: HK |
|
ASS | Succession or assignment of patent right |
Owner name: ZYDUS BSV PHARMA PVT. LTD. Free format text: FORMER OWNER: ZYDUS BSV R + D PVT. LTD. Effective date: 20110818 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C56 | Change in the name or address of the patentee |
Owner name: ZYDUS BSV R + D PVT. LTD. Free format text: FORMER NAME: BHARAT SERUMS + VACCINES LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: Ahmedabad Patentee after: Zidus BSV research and development Pte. Ltd. Address before: Ahmedabad Patentee before: BSV Research and Development Pte. Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20110818 Address after: Ahmedabad Patentee after: Zidus BSV pharmaceutical Pte. Ltd. Address before: Ahmedabad Patentee before: Zidus BSV research and development Pte. Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100616 Termination date: 20151231 |
|
EXPY | Termination of patent right or utility model |